Bard Associates’s Rayonier RYN Stock Holding History

Bard Associates’s Portfolio RYN Stock Details RYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-276	Closed	-$5.69K	–	337
2026 Q1	$5.69K	Buy	+276	New	+$6.08K	﹤0.01%	225

Other funds holding RYN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bard Associates's RYN Position: Q2 2026 in Review

Bard Associates sold out of Rayonier (RYN) in Q2 2026, closing a stake of 276 shares — an estimated $5.69K sold.

Bard Associates first reported a position in RYN in Q1 2026 and held it in 1 quarter. The position peaked at $5.69K in Q1 2026. 456 funds tracked by Wall St. Rank hold RYN as of Q2 2026.

Bard Associates reported no remaining Rayonier position as of Q2 2026 after selling out during the quarter.
Bard Associates sold 276 Rayonier shares in Q2 2026, an estimated $5.69K.
Bard Associates first reported a position in Rayonier in Q1 2026 and held it in 1 quarter.
Bard Associates's Rayonier position peaked at $5.69K in Q1 2026.
456 funds tracked by Wall St. Rank held Rayonier as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.